Latest News Archive
Please select Category, Year, and then Month to display items
13 August 2024
|
Story Anthony Mthembu
|
Photo Sibahle Dayimani and Amandla Kulu
Prof Peter Roseel, Managing Director of Management Consulting and Research – a spin-off of the Catholic University of Leuven in Belgium; and Prof Nicolene Barkhuizen, Director of the UFS Business School.
The Business School at the University of the Free State (UFS) hosted Prof Peter Rosseel, Managing Director of Management Consulting and Research – a spin-off of the Catholic University of Leuven in Belgium – for a guest lecture during his visit to the UFS Faculty of Economic and Management Sciences (EMS).
The guest lecture took place on 19 July 2024 in the Business School Auditorium and was attended by academics from the UFS.
Reflecting on the lecture
The lecture presented by Prof Rosseel focused on how combining strategy, strategy implementation, culture transformation, leadership, and learning successfully leads to sustainable growth, creates engagement, and delivers tangible results. Throughout the lecture, Prof Rosseel spoke about how experts tend to make bad leaders and therefore stop change from happening within an organisation. In fact, he highlighted that, “Experts stop change from happening within the workplace because experts, by definition, look through the eyes of their expertise, but you cannot reduce the world to different forms of expertise, as it is holistic.” As such, he argued that to change an organisation, one must see things from the point of view of others.
Furthermore, Prof Rosseel delved deeper into the hierarchical operating model within organisations. He indicated that the above model should be one community within organisations; however, unfortunately it is not. This is because organisations are made up of several departments such as finance and human resources. As such, he regards these departments to be silos that could prove to be detrimental to organisations, as each silo can create its own culture as opposed to an organisational culture. These are some of the points he discussed throughout the lecture.
After the lecture concluded, the audience had the opportunity to engage with Prof Rosseel on his viewpoints. In fact, Lyle Markham, Academic Head of Department and Lecturer in Industrial Psychology at the UFS, was one of the audience members and described the lecture as insightful.
DNA sequencer launched at the UFS
2013-11-25
 |
| Dr Gansen Pillay, Deputy Chief Executive Officer of the National Research Foundation, explaining to the scholars what will be expected of them. |
The University of the Free State (UFS) can now collect immensely valuable data on drug resistance in HIV/Aids and TB with the new DNA sequencer that was launched recently at the International workshop on HIV/AIDS and TB drug resistance at the Bloemfontein Campus.
The DNA sequencer will allow the Free State province to produce viral and bacterial genetic data to fight the local development of HIV/ Aids and TB drug resistance.
The HIV and TB epidemics have expanded very fast and South Africa now has the largest HIV and TB treatment programme in the world, with over 2 million patients on treatment. However, these successful treatment programmes are now being threatened by the appearance of drug resistance.
The Free State province has been at the forefront of fighting HIV drug resistance in South Africa and has one of the most advanced treatment programmes for the management of resistance strains in the country. In addition, researchers at the University of the Free State are leading partners in the Southern African Treatment and Resistance Network (SATuRN; www.bioafrica.net/saturn), a research network that has trained over 2 000 medical officers in the treatment of drug resistance strains.
The Department of Medical Microbiology and Virology in the Medical School at the UFS has partnered with the provincial department of health, the Medical Research Council (MRC) and the Delegation of the European Union to South Africa to fund a dedicated DNA sequencer machine that will be used to generate HIV and TB drug-resistance results. This new machine will enable cutting-edge research to take place, using the data in the province and, importantly, support patients with resistance strains to have access to advanced genotypic testing techniques.
“HIV drug resistance is a very serious problem in South Africa, and the recent advances in DNA testing technology allow clinicians in the province to access drug resistance testing, which enables them to manage patients appropriately who fail treatment, and use the results to cost-effectively extend and improve patients’ lives,” says Dr Cloete van Vuuren, Specialist in Infectious Diseases at the UFS’s Faculty of Health.
Dr Dominique Goedhals, pathologist from the Department of Medical Microbiology and Virology at the UFS, adds: “We have been looking forward to expanding our work with the clinicians and researchers, using DNA sequencing to shed light on the causes and consequences of drug resistance in urban and rural settings in the province.”